5-((3-(benzo[d]thiazol-2-yl)phenylamino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione

ID: ALA1078340

PubChem CID: 46882631

Max Phase: Preclinical

Molecular Formula: C20H16N2O4S

Molecular Weight: 380.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)OC(=O)C(=CNc2cccc(-c3nc4ccccc4s3)c2)C(=O)O1

Standard InChI:  InChI=1S/C20H16N2O4S/c1-20(2)25-18(23)14(19(24)26-20)11-21-13-7-5-6-12(10-13)17-22-15-8-3-4-9-16(15)27-17/h3-11,21H,1-2H3

Standard InChI Key:  UZIRVOZNNDDYEZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    6.8429  -25.8266    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.0227  -25.7217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6727  -26.4708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2752  -27.0356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9980  -26.6376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7039  -27.0643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6869  -27.8889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9641  -28.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2582  -27.8602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2612  -20.7161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8486  -20.0019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0235  -20.0019    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6109  -20.7161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0235  -21.4304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8486  -21.4304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7858  -20.7161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2612  -22.1446    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6109  -22.1446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0235  -22.8588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6109  -23.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0235  -24.2873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6109  -25.0062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7858  -25.0062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3732  -24.2873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7858  -23.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4314  -19.2852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5591  -19.5832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  2  0
  8  9  1  0
  4  9  2  0
  5  6  2  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 10 15  1  0
 13 16  2  0
 15 17  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 20 25  2  0
 19 20  1  0
 18 19  1  0
 14 18  2  0
  1  5  1  0
 11 26  1  0
  6  7  1  0
 11 27  1  0
 22  2  1  0
M  END

Associated Targets(Human)

MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 2 (5592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.43Molecular Weight (Monoisotopic): 380.0831AlogP: 4.10#Rotatable Bonds: 3
Polar Surface Area: 77.52Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.35CX Basic pKa: 2.02CX LogP: 4.30CX LogD: 4.30
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.42Np Likeness Score: -1.55

References

1. Darque A, Dumètre A, Hutter S, Casano G, Robin M, Pannecouque C, Azas N..  (2009)  Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates.,  19  (20): [PMID:19748781] [10.1016/j.bmcl.2009.08.013]

Source